Data / Form D filings / CHITOGEN INC
CHITOGEN INC: Form D filings
CHITOGEN INC, a biotechnology company in Plymouth, MN, filed 7 Form D notices with the SEC between 2013 and 2023. The latest, on December 13, 2023, reports an offering of $1.1 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12805 HWY 55, SUITE 202, Plymouth, MN, 55441
- Phone
- (763) 559-5670
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Minnesota
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1470264
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | New notice | $1,050,000 | $0 | $1,050,000 | 0 | Yet to occur | sec.gov |
| Dec 16, 2022 | New notice | $750,000 | $0 | $750,000 | 0 | Yet to occur | sec.gov |
| May 6, 2022 | Amendment | $523,500 | $523,500 | 13 | Aug 10, 2018 | sec.gov | |
| Oct 9, 2018 | New notice | $500,000 | $207,000 | $293,000 | 7 | Aug 10, 2018 | sec.gov |
| May 29, 2015 | New notice | $2,999,999 | $35,000 | $2,964,999 | 1 | May 12, 2015 | sec.gov |
| Jul 2, 2014 | Amendment | $1,548,150 | $1,548,150 | 23 | Oct 31, 2013 | sec.gov | |
| Nov 13, 2013 | New notice | $1,500,000 | $105,000 | $1,395,000 | 2 | Oct 31, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yong Zhu | Director | |
| Steve Muellerleile | Executive Officer | |
| Frederick Albright | Director | |
| Douglas Eayrs | Executive Officer, Director | |
| James Drake | Director | |
| Robert Levy | Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Dec 11, 2023 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CHITOGEN INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.